Metabolic derangements are intimately connected with changes in biofluid biomarkers, but not yet objectively associated with neuropsychiatric syndromes. We discuss potential uses of biomarkers for neuropsychiatric diagnoses and drug response.
Moderators: Zahinoor Ismail, Fabricio Oliveira
Panelists: George Perry, Ramit Ravona-Springer
To register for the live event, please visit: https://alz-org.zoom.us/webinar/register/WN_x_n5d5EFS5i062QcYd7wPQ